Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To qualitatively analyze the supportive care needs (including health education and nursing care) of anal fistula patients after fistulotomy using the Kano model.

Methods: A total of 183 anal fistula patients who underwent fistulotomy from December 2021 to December 2023 were selected via cluster sampling. Sociodemographic data were collected, and a self-designed questionnaire based on the Kano model (validated through two rounds of expert consultation and referring to the related literature) was used to assess patients' supportive care needs. The questionnaire covered health education needs (eg, delivery methods, content) and nursing needs (eg, physiological and psychological support). Satisfaction indices (SI), dissatisfaction indices (DSI), and a DSI-SI matrix were calculated.

Results: Among 12 health education needs, 3 were Must-be (M) (25.00%), 4 were One-dimensional (O) (33.33%), 4 were Attractive (A) (33.33%), and 1 was Indifferent (I) (8.33%). The DSI-SI matrix identified 2 high-priority (16.67%), 2 to-be-improved (16.67%), 3 secondary-improvement (25.00%), and 5 low-priority (41.67%) items. Among 12 nursing needs, 2 were M (16.67%), 3 were O (25.00%), and 7 were A (58.33%). The matrix showed 1 high-priority (8.33%), 1 to-be-improved (8.33%), 1 secondary-improvement (8.33%), and 9 low-priority (41.67%) items.

Conclusion: The Kano model effectively identifies supportive care needs for anal fistula patients post-surgery, providing a comprehensive basis for precision treatment and postoperative nursing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399089PMC
http://dx.doi.org/10.2147/JMDH.S535960DOI Listing

Publication Analysis

Top Keywords

supportive care
16
anal fistula
16
fistula patients
16
kano model
12
based kano
8
health education
8
care anal
8
dsi-si matrix
8
low-priority 4167%
8
care
5

Similar Publications

Home parenteral nutrition (HPN) is a life-sustaining therapy traditionally used as a bridge to enteral autonomy or intestinal transplantation. Increasingly, it is used for intractable feeding intolerance (IFI), which can occur near the end of life (EOL) in children with severe neurological impairment (SNI). In these cases, HPN use differs from its historical role and requires tailored outpatient planning.

View Article and Find Full Text PDF

Estimating Health State Utilities for IDH-Mutant Diffuse Glioma.

Pharmacoecon Open

September 2025

Acaster Lloyd Consulting Ltd, Lacon House, 84 Theobalds Rd, London, WC1X 8NL, UK.

Background: Isocitrate dehydrogenase-mutant (mIDH) gliomas are malignant central nervous system tumours. After initial resection, patients with mIDH gliomas with favourable prognosis may live without receiving oncologic treatment for years, but ultimately patients will experience recurrence and require radio- and/or chemotherapy (RT/CT). Cost-utility analyses (CUA) can explore the value of treatments that delay recurrence and initiation of RT/CT.

View Article and Find Full Text PDF

Prospective validation of the Nottingham Hip Fracture Score for predicting 1-year mortality in a Spanish cohort.

Br J Anaesth

September 2025

Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i la Salut a la Catalunya Central (IrisCC), Vic, Barcelona, Spain; Department of Internal Medicine, Hospital d'Olot i comarcal de la Garrotxa, Olot, Girona, Spain; Faculty of Medicine, Univer

View Article and Find Full Text PDF

Pharmacogenetics in oncology: Unveiling its potential in treatment personalization and beyond.

Bull Cancer

September 2025

Department of Pathology and Medical Biology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.

The effectiveness and tolerability of medicines can vary considerably from person to person, even at the same dose. This variation is influenced by many factors, including constitutional genetic characteristics. In fact, some people have genetic variations that are common and neutral in the population, known as polymorphisms, which can affect drug metabolism or make them more susceptible to certain adverse effects.

View Article and Find Full Text PDF

Introduction: One of the current challenges in Parkinson's disease (PD) and other movement disorders (MD) is how and when to apply palliative care. Aware of the scarce training and implementation of this type of approach, we propose some consensual recommendations for palliative care (PC) in order to improve the quality of life of patients and their environment.

Material And Methods: After a first phase of needs analysis through a survey carried out on Spanish neurologists and a review of the literature, we describe recommendations for action structured in: palliative care models, selection of the target population, when, where and how to implement the PC.

View Article and Find Full Text PDF